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Peyer’s patches (PPs) are primary inductive sites of
mucosal immunity. Defining PPmononuclear phago-
cyte system (MPS) is thus crucial to understand the
initiation of mucosal immune response. We provide
a comprehensive analysis of the phenotype, distribu-
tion, ontogeny, lifespan, function, and transcriptional
profile of PPMPS. We show that monocytes give rise
to macrophages and to lysozyme-expressing den-
dritic cells (LysoDCs), which are both involved in par-
ticulate antigen uptake, display strong innate anti-
viral and antibacterial gene signatures, and, upon
TLR7 stimulation, secrete IL-6 and TNF, but neither
IL-10 nor IFNg. However, unlike macrophages, Ly-
soDCs display a rapid renewal rate, strongly express
genes of the MHCII presentation pathway, and prime
naive helper T cells for IFNg production. Our results
show that monocytes differentiate locally into Ly-
soDCs andmacrophages, which display distinct fea-
tures from their adjacent villus counterparts.INTRODUCTION
To protect our body from harmful agents, the mammalian small
intestine possesses specific sentinel sites called Peyer’s
patches (PPs) where mucosal immune response initiation and
generation of immunoglobulin A-producing B cells take place
(Macpherson et al., 2012). PPs comprise clustered domes
formed by B cell follicles separated from each other by interfol-
licular regions (IFRs) enriched in T cells. The follicle-associated
epithelium (FAE) contains specialized epithelial cells, called M
cells, that bind and rapidly transport microorganisms from the
lumen to the subepithelial dome (SED) (Owen and Jones, 1974;
Schulz and Pabst, 2013). There, antigen uptake, degradation,
and presentation by cells of the mononuclear phagocyte system
(MPS) are crucial steps to induce themucosal immune response.
The MPS comprises monocytes, dendritic cells (DCs), and mac-
rophages. PP DCs encompass five different subsets: plasmacy-
toid DCs (pDCs), CD8a+ DCs, CD11b+ DCs, double-negative
DCs (DN DCs), and lysozyme-expressing DCs (LysoDCs)770 Cell Reports 11, 770–784, May 5, 2015 ª2015 The Authors(Contractor et al., 2007; Iwasaki and Kelsall, 2001; Lelouard
et al., 2010). The pDCs and DN DCs are mainly located in the
SED and in the IFR, whereas CD8a+ DCs are situated in the
IFR and CD11b+ DCs and LysoDCs in the SED. In addition, DN
DCs and LysoDCs can penetrate into the FAE where they
interact with M cells (Iwasaki and Kelsall, 2001; Lelouard et al.,
2012).
Among PP DCs, LysoDCs are the most efficient at taking up
pathogenic bacteria, dead cells, and particulate antigens in vivo
(Lelouard et al., 2010, 2012). Moreover, they are able to inter-
nalize luminal antigens by extending dendrites into the gut lumen
throughM cell-specific transcellular pores (Lelouard et al., 2012).
Although Salmonella Typhimurium is mainly internalized by
LysoDCs, which express the chemokine receptor CX3CR1, the
associated immune response seems to be mediated by
CCR6+CX3CR1
 DCs, which correspond either to DN DCs or
CD11b+ DCs (Lelouard et al., 2010; Salazar-Gonzalez et al.,
2006; Zhao et al., 2003). DN DCs and CD8a+ DCs produce IL-
12 in response to bacterial stimulation, while CD11b+ DCs pro-
duce IL-10 and IL-6 and induce IgA secretion in vitro (Iwasaki
and Kelsall, 2001; Sato et al., 2003). CD11b+ DCs also are able
to prime naive T cells to secrete IL-4 and IL-10 (Iwasaki and Kel-
sall, 2001). However, since LysoDCs express high levels of
CD11b and can’t be discriminated from CD11b+ DCs based on
commonly used criteria of isolation (e.g., CD11c, MHCII, and
CD11b), it is yet unknown whether these functional properties
are shared by both of these PP DC subsets. Moreover, it is worth
noting that no distinction has been made so far between DCs of
the dome and DCs of dome-associated villi (DAVs), which could
have been co-isolated and might have distinct properties.
Unlike PP DCs, the phenotype, diversity, immune functions,
and distribution of macrophages in PPs are still unknown due
to the lack of reliable markers.
Here we used a combination of comparative transcriptional
analyses, multiparameter flow cytometry, and high-resolution
confocal microscopy to study the diversity, distribution, origin,
renewal, and function of the PP MPS. We show that dome
CD11chi lysozyme-expressing cells derive from CCR2+ mono-
cytes and are composed of LysoDCs and two macrophage sub-
sets. Conversely to villus macrophages, the latter do not express
the classic macrophage markers F4/80, CD64 (Fc Gamma Re-
ceptor I), CD169 (sialoadhesin), and CD206 (mannose macro-
phage receptor). Unlike dome macrophages, LysoDCs have a
rapid turnover and can efficiently prime naive T cells toward a
Th1 phenotype in vitro.
RESULTS
Phenotypic Distinction between Mononuclear
Phagocytes of the Dome and of the DAVs
PPs are constituted of dome and DAVs. A major issue when
analyzing the MPS of the dome after isolation of cells from PPs
is the presence of phagocytes extracted not only from the
dome but also from the DAVs.
By confocal microscopy, most CX3CR1-expressing phago-
cytes located in the SED and in the DAVs expressed CD11c
andSIRPa, but could be distinguished by the specific expression
of F4/80 and CD169 in the DAVs and of lysozyme in the SED (Fig-
ures 1A–1C). CD169 also was expressed by macrophages at the
base of the IFR (Figure S1A), whereas F4/80+ cells were either
rare or absent in the whole dome (Table S1). Thus, according
to these confocal microscopy data, we could establish a flow cy-
tometry gating strategy todistinguishPPphagocytesof thedome
from those of DAVs based on their F4/80 and lysozyme differen-
tial expression. To confirm this issue, we compared CD11c+ cells
isolated fromeither villi or PPs (Figure 1D). Unlike commonly used
methods, we applied short digestion time without prior EDTA
treatment before magnetic sorting of CD11c+ cells to avoid as
much as possible the release of DAV cells (Figure S1B). Using
these conditions, lysozyme-expressing cells were specifically
detected in the CX3CR1
hi gate of PP cells, but not in the villi (Fig-
ure 1D, P1; Figure S1B), confirming the absence of PPs in the vil-
lus fraction and the specific location of lysozyme-expressing
cells in the dome. The high number of F4/80hi cells in the PP frac-
tion indicated that an important part of the collectedCD11c+ cells
were issued from DAVs (Figure 1D, P2). Importantly, dome lyso-
zyme-expressing cells expressed similar levels of CX3CR1 as
CX3CR1
hiF4/80hi DAV phagocytes, but higher levels of CD11c
(Figure 1D; Figure S1B). The combination of SIRPa and CD11b
markers on the CD11chi fraction of cells (Figure 1D, P3) allowed
us to distinguish DAV DCs, expressing high levels of CD11b
and intermediate levels of SIRPa (Figure 1D, P4), from dome
phagocytes, expressing either higher levels of SIRPa (Figure 1D,
lysozyme-expressing cells, P1) or no or lower levels of CD11b
(Figures 1D and S1C, dome DN, CD11b+, and CD8a+ DCs iden-
tified as P5, P6, and P7, respectively). Finally, CD11c
hi lysozyme-
expressingcells couldbe split into twosubpopulations according
to their MHCII surface expression (Figure 1D, last column). Thus,
theMPS of DAVs (P2 and P4) and dome (P1, P5, P6, and P7) can be
distinguished based on a combination of markers, including
CD11c, F4/80, CD11b, and SIRPa.
Circulating Monocytes Give Rise to Both LysoDCs and
Macrophages in PPs
In the gut, CX3CR1
hi cells are mostly derived from Ly6ChiCCR2+-
circulatingmonocytes (Bogunovic et al., 2009; Varol et al., 2009).
The egress of these monocytes from the bone marrow (BM) into
the blood is largely dependent on the chemokine receptor CCR2,
and CCR2-deficient mice show a drastically reduced number of
circulating Ly6Chi monocytes (Serbina and Pamer, 2006). Given
that dome lysozyme-expressing cellswereCX3CR1
hi (Figure 1D),we investigated whether their number was altered in CCR2-defi-
cient mice. Surprisingly, we noticed that MHCIIhi lysozyme-ex-
pressing cells were strongly reduced in CCR2-deficient mice,
while those expressing low levels of MHCII were slightly or not
altered (Figures 2A and 2B). The latter were the only ones to ex-
press CD4 (Figure 2A). Moreover, as they strongly displayed
autofluorescence (AF), they most likely corresponded to
macrophages and were thus termed LysoMacs, whereas the
CD11chiMHCIIhiCD4AFlo/int cells were considered as LysoDCs.
Because our attempts to detect cells derived from transferred
monocytes into Ccr2/ mouse PPs were unsuccessful, we re-
constituted lethally irradiated CD45.1+CD45.2+ mice with a 1:1
mixture of BM cells isolated from wild-type (WT) CD45.1+ mice
and either CD45.2+Batf3/ or CD45.2+Ccr2/ mice. As ex-
pected, we found that LysoDCs derivedmostly fromCcr2+/+ pre-
cursors, while dome CD8a+, CD11b+, and DN DCs consisted of
both Ccr2+/+ and Ccr2/ donor cells (Figure 2C). Interestingly,
although LysoMacs were only slightly altered in CCR2-deficient
mice (Figure 2B), they mainly derived from Ccr2+/+ precursors,
too (Figure 2C). Moreover, LysoDCs and LysoMacs developed
irrespective of the presence of Batf3, while dome CD8a+ DCs
derived mainly from Batf3+/+ donor cells (Figure 2C), confirming
that Batf3 is required for the differentiation of dome CD8a+ DCs
(Hildner et al., 2008). Dome CD11b+ and DN DCs derived prefer-
entially but not exclusively from Batf3/ precursors, which
indicated that Batf3 deficiency could induce a competitive
advantage toward the dome CD11b+ and DN DC lineages. Alto-
gether, these data support the monocytic origin of LysoDCs and
LysoMacs and the common DC precursor (CDP) origin of dome
CD8a+, CD11b+, and DN conventional DCs (cDCs).
Given that both LysoMacs and LysoDCs derived from
CCR2+/+ donor cells in competitive chimeric mice whereas
only LysoDCs were strongly altered in CCR2/ mice, we
investigated whether this discrepancy could be explained by
an embryonic origin and self-renewal of LysoMac through life
as recently demonstrated for most tissue macrophages (Hashi-
moto et al., 2013; Schulz et al., 2012; Yona et al., 2013). Parabi-
osis between CD45.1 and CD45.2 mice was established for
2 months and the contribution of non-host-derived cells to Ly-
soDCs, LysoMacs, and dome cDCs was assessed. Between
11% and 17% of dome cDCs and LysoDCs were of donor origin
(Figure 2D). Similarly, exchange of blood-borne cells reached
12% for LysoMacs, indicating that circulating precursors
contributed to the LysoMac population (Figure 2D). Moreover,
when parabiosis was established between CCR2-deficient
mice and WT mice, the Ccr2/ parabionts contained 62%
and 94% of donor cells for LysoMacs and LysoDCs, res-
pectively, whereas chimerism was maintained below 16% for
dome cDCs (Figure 2E), confirming that both LysoDCs and Lyso-
Macs derived mainly from circulating monocytes.
The difference in CCR2 dependency between LysoDCs and
LysoMacs might otherwise reflect differences in their renewal
rate. We compared turnover times of DAV and dome DCs and
macrophages using bromodeoxyuridine (BrdU) labeling. The
renewal rate of LysoMacs was very slow and comparable to
that of DAV macrophages, with less than 30% of cells being re-
placed by day 6 (Figure 2F). LysoDCs displayed a rapid turnover
reaching 61% ± 9% of cell replacement at day 6 (Figure 2F). TheCell Reports 11, 770–784, May 5, 2015 ª2015 The Authors 771
Figure 1. Phenotypic Distinction between Mononuclear Phagocytes of the Dome and of the DAVs
(A–C) Confocal microscopy projection of CX3CR1-EGFP
/+ mouse PP sections stained for EGFP (green), CD11c (red), lysozyme (yellow), CD3 (cyan), and (A)
F4/80, (B) CD169, or (C) SIRPa (magenta). CX3CR1
+CD11c+ lysozyme+ cells of the SED expressed SIRPa, but neither F4/80 nor CD169, whereas the DAV
CX3CR1
+CD11c+lysozyme cells displayed all three markers. Bars, 20 mm.
(D) Flow cytometry analysis of villus and PP CD11c+-enriched cells. (First column) CX3CR1
hi lysozyme+ cells were only detected in PPs (P1). (Second column)
Villus and DAV F4/80hi cells (macrophages and eosinophils) expressed lower level of CD11c (P2) than DCs (P3). (Third column gated on P3) Villus and DAVDCs (P4)
displayed lower levels of SIRPa than dome CX3CR1
hiCD11chi lysozyme+ cells (blue, P1) and higher levels of CD11b than dome DN (P5), CD11b
+ (P6), and CD8a
+
(P7) DCs. (Last column) DomeCX3CR1
hiCD11chi lysozyme+ cells (blue) expressed either high or low levels ofMHCII. See also Figure S1. Data are representative of
six independent experiments.
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turnover rates of dome cDCs were even faster, reaching 92% ±
9% at day 6 (Figure 2F). Thus, LysoDC number may be reduced
in CCR2-deficient mice due to their short lifespan and insufficient
circulating precursors to replace them, whereas the slow turn-
over of LysoMacs may allow their replenishment by fewer blood
monocytes.
Genetic Global Relationships among PP Phagocyte
Subsets
To perform a transcriptomic analysis of LysoDCs to be
compared to LysoMacs and to the dome CD11b+ cDCs, we
needed to define a gating strategy to sort each CD11chi MHCII+
cell subset of the domewithout intracellular staining of lysozyme.
The pDCs were excluded based on their lower expression of
CD11c (Figure 3A). Surprisingly, BST2, a classic pDC marker
(Blasius et al., 2006), was found to be expressed at the surface
of LysoDCs and LysoMacs (Figure 3A). Thus, LysoDCs and Ly-
soMacs were separated from pDCs and cDCs based on
CD11c and BST2 expression, respectively (Figure 3B). LysoDCs
and LysoMacs were then separated using CD4 and MHCII
expression (Figure 3B). Finally, dome CD11b+ cDCs were distin-
guished from dome DN and CD8a+ cDCs and DAV DCs with
CD8a and the same combination of CD11b and SIRPa staining,
as shown in Figure 1D.
Triplicates of LysoDCs, LysoMacs, and dome CD11b+ cDCs
were analyzed by whole-mouse genome microarray. LysoDCs
and LysoMacs clustered separately from dome CD11b+ cDCs
(Figure S2A), and 106 differentially expressed genes were found
between LysoDCs and LysoMacs, whereas more than 850
genes distinguished dome CD11b+ cDCs from LysoMacs or Ly-
soDCs (Figure S2B). As expected, themain genes selectively ex-
pressed in the CDP-differentiation pathway (i.e., Flt3, Zbtb46,
and Id2) were weakly or not expressed in LysoDCs and Lyso-
Macs, while those of the monocyte/macrophage pathway of
differentiation (i.e., Csf1r and Mafb) were strongly expressed
(Figure S2C). Moreover, there was an increase or decrease of
the proportion of LysoDCs and LysoMacs among CD11chiMH-
CII+ cells upon treatment of mice with inhibitors of Flt3 (Quizarti-
nib) or CSF1 receptor (GW2580), respectively (Figure S2D). This
confirmed LysoDC and LysoMac dependency on CSF-1 recep-
tor, but not Flt3 signaling. In addition toMafb, other transcription
factor genes typically associated with monocyte gene signature
also were enriched in LysoDCs and LysoMacs (Figure S2E).
As expected, Ccr2 and Cx3cr1 were mainly expressed by Ly-
soDCs and LysoMacs, whereas Ccr6 and Ccr7 were mostly ex-
pressed by dome CD11b+ cDCs (Figure S2E). There was also a
differential expression of genes encoding cytokines (Il1a and
Tnfsf13b enriched in LysoDCs and LysoMacs, Il1b in LysoDCs
and CD11b+ cDCs, Il6 and Tnfsf9 in CD11b+ cDCs, and Tnfsf15
in LysoMacs) and chemokines (Cxcl10 enriched in LysoDCs and
LysoMacs, Ccl19 in LysoMacs, Ccl22 in CD11b+ cDCs, and
Cxcl14 in LysoDCs) (Figure S2E).
PP Monocyte-Derived Cells Display Antibacterial and
Antiviral Gene Signatures
BST2, which was used in our gating strategy to isolate LysoDCs
and LysoMacs, is an antiviral protein known to be induced by
type I interferon (IFN) and the transcriptional factor IRF7 (Begoet al., 2012; Blasius et al., 2006). We thus investigated the
expression of the IFN-signaling pathway genes. Type I IFN re-
ceptor genes (Ifnar1 and Ifnar2), Ikbke (IKKe), Irf7, and Irf8 were
indeed upregulated in LysoDCs and LysoMacs compared to
dome CD11b+ cDCs, whereas STAT and other IRF transcrip-
tional factor genes showed either lower (Irf4/5 and Stat4/5a) or
no differential expression (Figure 3C). Functional association
network analysis revealed that IRF7-associated genes also
were enriched in LysoDCs and LysoMacs (Figure 3D). Ikbke
and Irf7 both have been reported to be master regulators of
IFN-dependent antiviral immune responses (Honda et al.,
2005; Tenoever et al., 2007). Actually, genes encodingmolecules
participating in the recognition of virus, such as Ddx58 (RIG-I),
Ddx60, Ifi204 (IFI16), Tlr7, Tlr9, Tmem173 (STING), and Zbp1
(DAI) (Aoshi et al., 2011), as well as other IFN-stimulated genes
with previously well-described antiviral activity, such as Bst2,
Gbp, Ifit,Oas,Oasl, Rnase l, and Rsad2 (viperin) (Sadler and Wil-
liams, 2008; Schoggins and Rice, 2011), were upregulated in Ly-
soDCs and LysoMacs (Figure 3E), indicating that monocyte-
derived cells may be key players in the innate immune response
against viral infection in PPs.
LysoDCs and LysoMacswere also better equipped to respond
to bacterial infection than dome CD11b+ cDCs. They were
enriched in bacterial-sensing (Tlr andNaip) genes as well as anti-
bacterial immunity-related genes, such as Aoah (acyloxyacyl hy-
drolase), Irg1, and Lyz1 (lysozyme P) (Figure 3F). LysoDCs and
LysoMacs were also strongly enriched in genes associated
with transition metal transport and sequestration, a mechanism
of host defense against bacterial infection known as nutritional
immunity (Hood and Skaar, 2012; Figure 3F). Among them,
Hamp (hepcidin),Hp (haptoglobin), and Tfrc (transferrin receptor)
were specifically enriched in LysoDCs, whereas Slc11a1
(NRAMP1) and Slc40a1 (ferroportin) were upregulated in Lyso-
Macs, indicating distinct mechanisms of iron availability regula-
tion for LysoDCs and LysoMacs.
Altogether these data indicate that LysoDCs and LysoMacs,
but not dome CD11b+ cDCs, display strong innate defense
mechanisms against viral and bacterial infections.
LysoDCs Display the Functional Gene Signature of a
Non-inflammatory Monocyte-Derived DC
Recognition of pathogens also occurs through C-type lectin re-
ceptors (CLRs) (Sancho and Reis e Sousa, 2012). Several CLR
genes were selectively expressed either by LysoMacs (Clec1b
and Clec7a encoding Dectin-1; Figure 4A) or by LysoDCs
(Clec4a1, Clec4a2, and Clec4n encoding Dectin-2; Figure 4A).
Actually, the top 20 of LysoDC-upregulated genes versus Lyso-
Mac included three CLR-encoding genes, Clec4a1, Clec4a2,
and Clec4a4 (Figure 4B). CLEC4A4/DCIR2 is a classic CD11b+
cDC marker recognized by the 33D1 antibody (Dudziak et al.,
2007). Its expression by LysoDCs and dome DN and CD11b+
cDCs, but not by LysoMacs or dome CD8a+ cDCs, was
confirmed by flow cytometry (Figure 4C). We further checked
the specificity of this gene by integrating the MPS gene expres-
sion data from the ImmGen project (Heng et al., 2008) and found
that it was neither expressed by macrophages nor monocytes
(Figure 4D). Sucnr1, which codes for the succinate receptor
GPR91, also was found to be highly specific of LysoDCs andCell Reports 11, 770–784, May 5, 2015 ª2015 The Authors 773
Figure 2. Dual Differentiation of Monocytes into LysoDCs and Macrophages
(A) AF and expression of CD4 was compared in PP MHCIIlo (blue) and MHCIIhi (red) CD11chi lysozyme+ cells of WT (top) and CCR2-deficient mice (bottom).
LysoDCs, which were weakly autofluorescent lysozyme+ cells expressing high levels of MHCII, but no CD4, were strongly reduced in CCR2-deficient mice
conversely to AFhiMHCIIloCD4+ lysozyme+ cells hereafter referred to as LysoMacs.
(B) Absolute numbers of LysoDCs and LysoMacs extracted from PPs of WT and CCR2/ mice are shown (mean ± SD; ***p < 0.001, Student’s t test).
(C) Expressions of CD45.1 and CD45.2 in the PP MPS of lethally irradiated CD45.1 3 CD45.2 mice reconstituted with equal amounts of CD45.1+ WT and
CD45.2+Ccr2/ or CD45.2+ Batf3/ BM cells. LysoDCs and LysoMacs were derived specifically from CCR2-expressing cells and CD8a+ DCs from Batf3-
expressing cells.
(legend continued on next page)
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of a very restricted number of CD11b+ cDC subsets (mainly
dome CD11b+ cDCs and spleen CD4+ cDCs; Figure 4D).
The top 20 of LysoDC-upregulated genes versus LysoMac
also comprised four transcripts related to the MHCII presenta-
tion pathway (Figure 4B), among which H2-Eb2 was not ex-
pressed by any macrophage or monocyte population of the
ImmGen database (Figure S3A). Several other genes linked to
this pathway also were upregulated in LysoDCs and dome
CD11b+ cDCs (Figure S3B). These data indicated that LysoDCs
are fully equipped to present antigens as efficiently as CD11b+
cDCs, while LysoMacs are not.
Finally, of the 71 LysoDC-upregulated genes as compared to
LysoMac (Figure S2B), 51 also were upregulated in dome
CD11b+ cDCs, among which 20 were known to be involved in
DC functions and ten even belonged to the core DC signature,
as defined byMiller et al. (Miller et al., 2012; Figure 4E). However,
LysoDCs did not express the monocyte-derived inflammatory
DC markers (Cheong et al., 2010; Serbina et al., 2003; Siddiqui
et al., 2010): Ly6c1 (Ly6C), Cd209a (DC-SIGN), Cdh1 (E-Cad-
herin),Nos2 (iNOS), or Tnf (Figure S3A). Moreover, LysoDCs dis-
played a similar distribution and were in comparable proportion
among CD11chiMHCII+ cells in conventional and germ-free
mice, which are devoid of any potential food and microflora-
induced stimulus, confirming their non-inflammatory nature (Fig-
ure 4F). Thus, LysoDCs are fully differentiated monocyte-derived
non-inflammatory cells, which differ from macrophages by a
gene signature linked to DC functions.
Diversity and Distribution of PP Macrophages
FcgrI (encoding CD64, the Fc Gamma receptor I), expressed
virtually by all monocyte and macrophage populations (Gautier
et al., 2012; Tamoutounour et al., 2012), was not expressed by
LysoMacs (Figure S4). We also confirmed at the gene level the
absence of F4/80 (Emr1) and CD169 (Siglec1), and we found
that the other classic macrophage markers, CD14 and CD206
(Mrc1), were not expressed by LysoMacs, although present in
villus macrophages (Figure S4). These data confirmed the atyp-
ical expression of genes in dome macrophages as compared to
other tissue macrophages.
Cd4 and Timd4were themost upregulated transcripts in Lyso-
Macs as compared to LysoDCs (Figures 5A and 5B). TIM-4, the
phosphatidylserine receptor encoded by Timd4 (Miyanishi et al.,
2007), was expressed at the surface of half of the LysoMacs (Fig-
ure 5C). We took advantage of CD4 and TIM-4 as discriminative
markers to study the distribution of LysoDCs and LysoMacs by
microscopy. In addition to their main location, i.e., the SED, Ly-
soDCs and LysoMacs were scattered throughout the follicle
(Figure 5D; Figure S5A). TIM-4+ LysoMacs were located in
the lower part of the follicle, whereas TIM-4 LysoMacs were
situated in the upper part and in the SED (Figure 5D). TIM-4+
LysoMacs also were present at the periphery and inside the
IFR enriched in T cells (Figure 5E). We have shown previously(D and E) Parabiotic pairs were generated from CD45.1+ and either (D) CD45.2+ W
MPS subset was determined 2 months after surgery. LysoDCs and LysoMacs w
(F) Kinetics of BrdU labeling administrated to mice for 6 days. LysoDCs reached 6
barely reached 30%. Results are shown asmean ±SD. Data are from two (D and E
to six mice per experiment.that tingible-body macrophages (TBMs) of the PP germinal cen-
ters (GCs) are devoid of most MPS surface markers, such as
CD11c, CD11b, F4/80, CD169, and MHCII (Lelouard et al.,
2010). Here we observed that TBMs displayed CD4 and TIM-4
on their surface (Figure 5F). PP serosal macrophages were
also CD4+TIM-4+ (Figure 5F; Table S1). Finally, DAV macro-
phages expressed CD4. Thus, CD4 seems to be a general sur-
face marker of small intestine macrophages.
Altogether, our data identified five different CD4+ macrophage
subsets in PPs: TIM4+ TBMs in the GC, CD169+TIM-4+ and
CD169TIM-4+ serosal macrophages, TIM-4 LysoMacs in the
SED and the upper part of the follicle, and, lastly, TIM-4+ Lyso-
Macs in the IFR and the lower part of the follicle (Table S1).
Both LysoDCs and TIM-4 LysoMacs Are Involved in
Particulate Antigen Uptake and, upon TLR7 Stimulation,
Secrete IL-6 and TNF
Lysozyme-expressing cells previously were identified as the
main particulate antigen and pathogenic bacteria-sampling cells
in the SED (Lelouard et al., 2010, 2012). However, no distinction
wasmade between LysoDCs and LysoMacs. Here we found that
CX3CR1 was not required for the formation of trans-M cell den-
drites and that most lysozyme-expressing cells extending these
dendrites did not express CD4 (40 CD4 cells among 50 lyso-
zyme-expressing cells extending dendrites examined; Fig-
ure S5B), indicating that these cells were mainly LysoDCs.
Nevertheless, TIM-4 LysoMacs, but neither cDCs nor other
SED cells, were able to internalize microspheres administrated
orally as efficiently as LysoDCs (Figure 6A).
We next investigated the ability of LysoDCs and LysoMacs to
upregulate MHCII and costimulatory molecules and secrete cy-
tokines upon in vitro stimulation with R848, an agonist for TLR7
whose gene was strongly enriched in LysoDCs and LysoMacs
as compared to dome CD11b+ cDCs (Figure 3E). Upon stimula-
tion, expression of MHCII, CD40, and CD86 increased at the
surface of LysoDCs, whereas only a slight but not significant
increase of CD40 and CD86 was observed for LysoMacs (Fig-
ure 6B). TLR7 activation also induced IL-6 and TNF secretion
by LysoDCs and to a lesser extent by LysoMacs, whereas
no IL-10 or IFNg production was observed for any subset
(Figure 6C).
Unlike LysoMacs, LysoDCs Efficiently Prime Naive
Helper T Cells to Induce a Th1 Immune Response
To determine whether LysoDCs or LysoMacs could interact with
and prime naive helper T (Th) cells, each dome DC subset and
LysoMacs were isolated, pulsed with ovalbumin (OVA), and
co-cultured with naive OVA-specific Th cells (Barnden et al.,
1998). Strikingly, after 16 hr of co-culture, strong interactions be-
tween LysoDCs and naive Th cells were observed, whereas only
phagocytized Th cells could be seen for LysoMacs (Figure 6D;
Movies S1, S2, and S3). Moreover, the number of Th cellsT mice or (E) Ccr2/mice. The percentage of non-host cells among each PP
ere derived from CCR2-dependent circulating precursors.
1% of BrdU incorporation at day 6, whereas DAVmacrophages and LysoMacs
) to three independent experiments (A, B, C, and F), with pooled cells from three
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Figure 3. PP Monocyte-Derived Cells Express BST2 and Display Strong Innate Antiviral and Antibacterial Gene Signatures
(A) Surface expression of CD11c and Bst2 (top) allowed us to distinguish LysoDCs/LysoMacs (blue) from other CD11chi cells (gray) and from pDC (red), as
confirmed by B220 and lysozyme staining (bottom).
(B) Gating strategy for LysoDC, LysoMac, and dome CD11b+ cDC sorting is shown.
(C) Heatmap of the type I IFN-signaling pathway and associated transcription factor gene expression in domeCD11b+ cDCs, LysoDCs, and LysoMacs. Type I IFN
receptor (IFNAR1 and IFNAR2), IkB kinase ε, IRF7, and IRF8 gene expression was upregulated in LysoDCs and LysoMacs as compared to dome CD11b+ cDCs.
Fold change (F.C.) is indicated on the right.
(D) Confidence view shows the IRF7 functional association network upregulated in LysoDCs and LysoMacs as compared to dome CD11b+ cDCs (fold change
indicated in brackets) using String 9.1 database with Bst2 and Irf7 as input nodes.
(E and F) Heatmaps illustrate the upregulation of viral sensing (E, top), antiviral (E, bottom), and antibacterial (F) genes in LysoDCs and LysoMacs as compared to
dome CD11b+ cDCs. See also Figure S2. Data are from three independent cell-sorting experiments with pooled cells from 42 mice per experiment.
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Figure 4. LysoDCs Are Non-inflammatory Monocyte-Derived Cells with a Gene Signature Linked to DC Functions
(A) Heatmap shows CLR genes with differential expression between monocyte-derived cells and dome CD11b+ cDCs, LysoMacs or LysoDCs and the other two
subsets, and finally DCs and LysoMacs. Fold change (F.C.) is indicated on the right.
(B) Top 20 of LysoDC-upregulated genes as compared to LysoMac. MHCII presentation pathway and CLR genes are in red and green, respectively.
(C) Surface expression of CLEC4A4 in dome CD8a+ (magenta), CD11b+ (orange), and DN (blue) cDCs, and in LysoMacs (red) and LysoDCs (green). Isotype
control staining (gray) allowed us to appreciate the high AF of LysoMacs.
(D) Normalized mean relative expression ± SD of Clec4a4 and Sucnr1 in the MPS of different tissues. Data are taken from the ImmGen database (Heng et al.,
2008).
(legend continued on next page)
Cell Reports 11, 770–784, May 5, 2015 ª2015 The Authors 777
interacting with LysoDCs increased when LysoDCs were stimu-
lated with R848 (Figure 6D; Movies S4 and S5).
After 5 days of co-culture, LysoDCs and dome cDC subsets
induced naive Th cell proliferation efficiently, whereas LysoMacs
did not (Figure 7A). When stimulated with R848, LysoDCs signif-
icantly increased their ability to induce Th cell proliferation,
whereas weak Th cell proliferation was observed with stimulated
LysoMacs. Altogether, our results indicate that unlike LysoMacs,
LysoDCs can process antigens adequately and prime naive Th
cells efficiently.
We then addressed the polarization of primed Th cells by intra-
cellular flow cytometry and cytometric bead array (Figures 7B
and 7C; Figure S6). Only background levels of secreted IL-4,
IL-10, and IL-17 were monitored (Figure 7C; Figure S6). Produc-
tion of IL-2 was induced by all DC subsets and, only after TLR7
stimulation, by LysoMacs (Figure S6). In accordance with a pre-
vious report (Sato et al., 2003), domeCD11b+ cDCs induced IL-6
production, but no TNF or IFNg (Figures 7B and 7C). A similar
profile of secretion was obtained for Th cells co-cultured with
dome DN cDCs (Figures 7B and 7C). LysoDCs and dome
CD8a+ cDCs primed naive Th cells to secrete IFNg (Figure 7B).
This production was further increased upon R848 stimulation.
Finally, R848 also promoted the production of IL-6 and TNF in
the supernatants of Th cells co-cultured with LysoDCs and, to
a lesser extent, with LysoMacs (Figure 7C). Thus, LysoDCs effi-
ciently prime naive Th cells to induce a Th1 immune response,
which is further amplified upon TLR7 stimulation.
DISCUSSION
In this study, we determined the phenotype, distribution, origin,
lifespan, and function of the PP MPS. Although monocyte-
derived DCs are widely used in vitro, their equivalent in vivo
mostly has been demonstrated in inflammatory conditions
(Cheong et al., 2010; Serbina et al., 2003), and whether mono-
cytes can give rise to DCs in the absence of inflammation still re-
mains a matter of debate (Geissmann et al., 2010; Hashimoto
et al., 2011; Jakubzick et al., 2013; Satpathy et al., 2012; Tamou-
tounour et al., 2013). Our results indicate that LysoDCs are
derived from monocytes. They express transcription factors
and growth factor receptors related to the monocyte, but not
to the CDP pathway of differentiation. Thus, they do not express
Flt3, which is required for cDC development in vivo (Bogunovic
et al., 2009; Ginhoux et al., 2009; Varol et al., 2009; Waskow
et al., 2008). Moreover, they are dependent on M-CSF, the
growth factor involved in monocytic progeny differentiation,
and on CCR2, the chemokine receptor that permits monocyte
egress from the BM (Serbina and Pamer, 2006). However, their
presence does not rely on microbial stimulation.(E) Heatmap shows LysoDC-upregulated genes as compared to LysoMac, for whi
with a fold change >2 between LysoDCs and LysoMacs using themin/maxmethod
gene signature (Miller et al., 2012).
(F) Similar proportion and distribution of LysoDCs in specific pathogen-free (SPF
shows LysoDCs/LysoMacs (CD11c in red, lysozyme in yellow) in the SED of SPF a
derived cells among CD11chi cells as well as the ratio of LysoDCs among monocy
population of CD11cintMHCIIhi cells (arrow) identified as B cells (B220+BST2 c
experiments with pooled cells from six mice per experiment. Bars, 20 mm. See a
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louard et al., 2010, 2012) that display some of the phenotypical
and functional characteristics of DCs. Phenotypically, in addition
to high level expression of CD11c and MHCII, they display the
33D1 antigen, CLEC4A4, which was the first specific mouse
DC marker to be described (Dudziak et al., 2007; Nussenzweig
et al., 1982). LysoDCs also express the succinate receptor
GPR91, whose expression in the MPS is restricted to a few
CD11b+ DC subsets. Interestingly, GPR91 is involved in sensing
danger, and, upon succinate triggering, promotes the migration
of DCs, their production of proinflammatory cytokines, and their
ability to prime Th cells (Rubic et al., 2008).
In addition to these DC phenotypic features, we also demon-
strate that they have a short half-life and are able to prime naive
Th cells in vitro for IFNg production. However, LysoDCs do not
express the chemokine receptor CCR7, which is required for
cDCs to migrate into T cell zones for antigen presentation. Since
the SED also is enriched in B and Th cells, CCR7-dependent
migration may not be required for antigen presentation in PPs.
It has now to be determinedwhether LysoDCs can prime effector
cells in vivo at this site of antigen uptake. Upon TLR7 activation,
LysoDCs secrete IL-6 and TNF and induce a higher production of
IFNg by Th cells. IL-6 is a cytokine known to play a major role in
the development of IgA-secreting B cells (Ramsay et al., 1994;
Sato et al., 2003). Previous reports have shown that PP DCs
and especially CD11b+ DCs are implicated in the differentiation
of naive B cells into IgA-producing plasma cells (Mora et al.,
2006; Sato et al., 2003). It remains to be established whether
these CD11b+ DCs are LysoDCs or domeCD11b+ cDCs. In sum-
mary, LysoDCs are steady-state monocyte-derived cells with
DC morphology, phenotype, and function.
Interestingly, in PPs, monocytes also can give rise to CD4+
cells that display the characteristics of macrophages, i.e.,
long-lived cells with strong phagocytic activity but poor naive
T cell-priming ability. Therefore, CD11chi lysozyme-expressing
cells are composed of two main subpopulations: LysoDCs,
which express CLEC4A4, high levels of MHCII, but no CD4;
and LysoMacs, which express CD4, low levels of MHCII, and
no CLEC4A4. In our previous studies, we could not distinguish
LysoMacs from LysoDCs and they were collectively termed Ly-
soDCs (Lelouard et al., 2010, 2012). We show here that, although
the trans-M cell sampling of luminal antigen by CD11chi lyso-
zyme-expressing cells is mainly mediated by LysoDCs, Lyso-
Macs can internalize particulate antigens very efficiently too,
probably after luminal antigen transport by M cells. Both Ly-
soDCs and LysoMacs display strong innate antiviral and anti-
bacterial gene signatures, which is consistent with the fact
that, as the first line of mononuclear phagocytes, they may
have to deal with many different kinds of pathogens. Half ofch expression also was upregulated in CD11b+ dome cDCs (51 of the 71 genes
, see Figure S2B). Genes involved in DC functions are in red. *Genes of the cDC
) and germ-free (GF) mice. (Left) Confocal microscopy of PP cryostat section
nd GF mice. (Right) Flow cytometry analysis shows that the ratio of monocyte-
te-derived cells were similar in SPF and GFmice. Note the loss of an important
ells, not shown) in GF mice. Results are representative of three independent
lso Figure S3.
Figure 5. Phenotype and Distribution of PP Macrophages
(A) Top 20 of LysoMac-upregulated genes as compared to LysoDC are shown.
(B) Normalized mean relative expression ± SD of Timd4 in LysoDCs, LysoMacs, and dome CD11b+ cDCs is shown.
(C) Surface expression of TIM-4 in CD11chi lysozyme+ cells is shown.
(D–F) Confocal microscopy projections of a C57Bl/6 mouse PP section stained for TIM-4 (green), CD11c (red), lysozyme (yellow), and CD4 (cyan). (D) LysoMacs
(CD11c+CD4+ lysozyme+ cells) of the lower part of the follicle (arrowheads) expressed TIM-4, whereas LysoMacs of the SED and of the upper part of the follicle
(arrows) did not. (E) LysoMacs of the IFR expressed TIM-4. (F) TBMs of the GC, which contained many apoptotic bodies (arrowheads; condensed nuclear
material, and apoptotic bodies in gray), expressed lysozyme, CD4, and TIM-4, but not CD11c. Data are representative of five independent experiments. Bars,
20 mm. See also Figure S4.LysoMacs display at their surface TIM-4, a phosphatidylserine
receptor (Miyanishi et al., 2007). The distribution of TIM-4+
macrophages correlates well with their proposed function inapoptotic effector cell clearance (Albacker et al., 2010, 2013),
since TIM-4+ LysoMacs and TBMs are located in zones of
effector cell priming and selection, i.e., IFRs for T cells andCell Reports 11, 770–784, May 5, 2015 ª2015 The Authors 779
Figure 6. Uptake of Particulate Antigens and TLR7 Activation Features of PP Monocyte-Derived Cells
(A) Unlike dome cDCs, LysoDCs and LysoMacs internalized microspheres efficiently. (Left) Confocal microscopy shows PPs from a C57BL/6 mouse fed with
0.2 mmYellowGreenmicrospheres for 24 hr (green) and stained for CD11c (red), lysozyme (yellow), andCD4 (cyan). In the SED,microsphereswere internalized by
LysoDCs (arrowhead) and LysoMacs (arrows). Bar, 20 mm. (Right) Percentages of LysoDCs, LysoMacs, and other SED cells that had engulfed microspheres are
shown. Quantitation was performed on three sections of two domes of two to three PPs for each of three mice (****p < 0.0001, one-way ANOVA followed by
Bonferroni).
(B) Fold changes of MHCII and co-stimulatory molecules median fluorescence intensity (MFI) in LysoDCs, LysoMacs, and dome CD11b+ cDCs cultured for 24 hr
with (stimulated) or without R848 (unstimulated, dashed line) are shown (n.s., non-significant; *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA followed by
Bonferroni).
(C) IL-6, IL-10, TNF, and IFNg secretions in the supernatant of LysoDCs, LysoMacs, and dome CD11b+ cDCs cultured for 24 hr with or without R848 were
determined by cytometric bead array (*p < 0.05, **p < 0.01, Student’s t test).
(legend continued on next page)
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GCs for B cells. Therefore, we propose a model in which part of
the pathogens entering through M cells would be destroyed
by TIM4 LysoMacs using their prominent innate defense mech-
anisms, while the other part would be killed and processed by
LysoDCs to be presented to Th cells tomount amucosal immune
response. This response would be then regulated at the level
of the GC and the IFR by TBM and TIM-4+ LysoMacs,
respectively.
Collectively, our results show that, in the same microenviron-
ment, monocytes develop into two closely related cell types
with different lifespan and functional properties. These mono-
cyte-derived cells differ greatly from their villous counterparts,
as evidenced by their lack of expression ofmost classic intestinal
macrophage markers. This indicates that the microenvironment
of the dome exerts a strong influence on the differentiation pro-
gram of monocytes. This strong imprinting pattern possibly re-
flects the crucial role of PPs in the mucosal immune response
initiation, and future studies of the genes specifically expressed
by the PPMPSwill likely help to understand themechanisms and
pathways involved in this process.
EXPERIMENTAL PROCEDURES
Antibodies
Antibodies used are listed in the Supplemental Experimental Procedures.
Animals
The 6- to 10-week-old C57BL/6 and OT-II mice were from Charles River Lab-
oratories.Ccr2/ andCx3cr1
GFPmice have been described previously (Boring
et al., 1997; Jung et al., 2000). All experiments were done in accordance with
French and European guidelines for animal care.
Parabiosis
Parabiotic mice were generated from age- and weight-matched CD45.1+
(C57BL/6) and CD45.2+ (C57BL/6 or CCR2/) mice that were between 6
and 10 weeks old.
Generation of BM Chimera
The 6- to 10-week-old C57BL/6 (CD45.1 3 CD45.2) mice were lethally irradi-
ated with two doses of 4 Gy each, 4 hr apart, and then injected intravenously
(i.v.) with at least 2.106 BM cells obtained from femurs and tibias of CD45.1
(C57BL/6) and CD45.2 (Ccr2/ or Batf3/) mice. Then, 8 weeks after recon-
stitution, the level of chimerism was determined.
Chemical Treatments
The drinking water of mice injected intraperitoneally (i.p.) with 1.5 mg BrdU
(Sigma-Aldrich) to ensure its immediate availability was supplemented for 1,
2, 4, and 6 days with 0.8 mg/ml BrdU. Mice were injected i.p. with 300 mg Qui-
zartinib (LC Laboratories), 2 3 400 mg GW2580 (LC Laboratories), or 10%
DMSO for 6 days before PP collection.
PP Cell Extraction
PPs were digested for 40min at room temperature with collagenase/DNase as
previously described (Lelouard et al., 2010). All subsequent procedures were
at 0C–4C. CD11c+ cells were sorted using anti-CD11c microbeads and an
AutoMACS magnetic cell separator according to the manufacturer’s instruc-
tions (Miltenyi Biotec).(D) (Left) 3D reconstruction shows LysoMacs (CD11c in green, lysozyme in red) an
with CTV-labeled naive OT-II T cells (cyan) with or without R848 for 16 hr. Note th
space, 5 mm. (Right) Number of T cells interacting with a single LysoDCwith or wit
three independent experiments). Results of (B and C) are mean ± SD of three inde
and Movies S1, S2, S3, S4, and S5.Flow Cytometry and Cell Sorting
CD11c+ were preincubated on ice for 10 min with the 2.4G2 antibody to block
Fc receptors, stained for surface markers, and then permeabilized for BrdU
and lysozyme labeling according to the manufacturer’s protocol (BrdU-label-
ing Flow kit, BD Biosciences). Cell viability was evaluated using Fixable
Viability Dye eFluor 506 (eBiosciences). Multiparameter flow cytometry and
cell sorting were performed using a FACS LSRII and a FACSAria III (BD Biosci-
ences), respectively. Data were analyzed with the BD FACSDiva software (BD
Biosciences).
RNA Isolation and Microarray Analyses
The total RNA of PP-sorted MPS cells from three independent experiments
was extracted with a QIAGEN micro RNAeasy PLUS kit. Quantity, quality,
and absence of genomic DNA contamination were assessed with a Bio-
analyser (Agilent Technologies). Microarray experiments were performed by
the Plateforme Biopuces of Strasbourg using the GeneChip Mouse Gene
1.0 ST array (Affymetrix; see the Supplemental Experimental Procedures).
Differentially expressed genes were determined using a stringent min/max
procedure (minimum expression among all replicates selected/maximum
expression among all other replicates) with a minimal fold change cutoff of
two. Gene fold change was given as the mean value of triplicates for subsets
displaying the highest and the lowest gene expression. Hierarchical clustering
with average linkage was performed with the Gene-E software. String 9.1
software was used to display functional association networks. Microsoft
Excel was used to generate heatmaps. Data from the ImmGen compendium
of mouse DC subsets were retrieved from NCBI GEO dataset GSE15907
(Heng et al., 2008) and normalized with our own data by Robust Multi-chip
Analysis.
Immunofluorescence Staining and Confocal Microscopy
PPs of mice fed or not with 0.2 m Fluoresbrite Yellow GreenMicrospheres (Pol-
ysciences) for 24 hr were fixed with Antigenfix (Diapath) for 1 hr, washed, and
processed as previously described (Lelouard et al., 2012). Slides were
observed with a Zeiss LSM 780 confocal microscope. Series of z sections
were taken for each field to control thatmicrosphereswere inside cells. Images
were analyzed using Adobe Photoshop CS6 and Imaris 6.1.
Stimulation of PP MPS Subsets and Priming of Th Cells In Vitro
Sorted PP MPS subsets (5 3 103) were cultured in RPMI-1640 supple-
mented with 10% fetal calf serum (FCS), 1% GM-CSF, 10% M-CSF, 1%
penicillin/streptomycin, 10 mM HEPES, 1 mM sodium pyruvate, 1 mM gluta-
mine, 1 mM non-essential amino-acids, and 50 mM 2-ME with or without
R848 (1 mg/ml). After 24 hr, MHCII, CD40, CD80, and CD86 surface expres-
sions were determined by flow cytometry. The concentrations of IL-6, TNF,
IL-10, and IFNg secreted in the culture supernatants were determined using
the mouse CBA inflammation kit (BD Biosciences), according to the manu-
facturer’s instructions. OT-II T cells were isolated from lymph nodes of
OT-II rag1/ mice (Barnden et al., 1998) using a CD4+ T cell-negative isola-
tion kit (Miltenyi). Purified OT-II T cells were incubated with 1 mM CellTrace
Violet (CTV; Life Technologies) for 12 min at 37C. CTV-labeled OT-II
T cells (3.5 3 104) were cultured together with sorted PP MPS subsets (3.5
3 103), pulsed for 2 hr at 37C with 200 mg/ml endotoxin-free OVA (Hyglos),
with or without R848 (1 mg/ml). After 5 days of co-culture, Th cells were re-
stimulated for 4 hr with 10 ng/ml PMA and 1 mg/ml ionomycin in the presence
of 10 mg/ml Brefeldin A. Proliferation was measured as a loss of CTV stain-
ing. IFNg production profile of OT-II T cells was determined by intracellular
staining. The concentrations of TNF, IFNg, IL-2, IL-4, IL-6, IL-10, and IL-17
secreted in the supernatants were determined using the mouse CBA Th1/
Th2/Th17 cytokine kit (BD Biosciences), according to the manufacturer’s
instructions.d LysoDCs (MHCII in green, lysozyme in red) pulsed with OVA and co-cultured
e different steps of degradation of the T cells internalized by a LysoMac. Grid
hout R848 stimulation is shown (***p < 0.001, Student’s t test; pooled data from
pendent experiments with 53 103 sorted cells/culture well. See also Figure S5
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Figure 7. Priming and Polarization of PP DC-Primed Helper T Cells
(A) Proliferation of OT-II T cells (3.5 3 104cells/condition) co-cultured for 5 days with the different PP phagocyte subsets (3.5 3 103cells/condition) pulsed with
OVA and stimulated or not with R848. A representative histogram is shown for each subset as well as a summary of three independent experiments.
(B) (Left) IFNg intracellular staining of OT-II T cells co-cultured for 5 days with the different PP phagocyte subsets pulsed with OVA and stimulated or not with R848
is shown. (Middle) Percentage of IFNg-producing cells among total Th cells is shown. (Right) IFNg secretion in the OT-II T cell co-culture supernatants was
determined by cytometric bead array.
(C) IL-6, IL-10, and TNF secretions in the OT-II T cell co-culture supernatants were determined by cytometric bead array. Results of (B andC) aremean ±SD. Data
are from three independent experiments with pooled cells from 42mice per experiment (n.s., non-significant; *p < 0.05, **p < 0.01, ****p < 0.0001, Student’s t test).
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Statistical Analysis
Results shown asmean ± SDwere compared with GraphPad Prism 6 software
using Student’s t test or one-way ANOVA followed by Bonferroni’s multiple
comparison test.
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